Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | BI-3802 |
Synonyms | |
Therapy Description |
BI-3802 is a BCL6 degrader, which reduces BCL6 levels and potentially decreases tumor growth (PMID: 37556508, PMID: 33208943). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
BI-3802 | BI 3802|BI3802 | BCL6 Inhibitor 6 | BI-3802 is a BCL6 degrader, which reduces BCL6 levels and potentially decreases tumor growth (PMID: 37556508, PMID: 33208943). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|